相关实验视频

Updated: Jan 17, 2026

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

对于遗传性聋的腺相关病毒基因疗法的早晨困境

Jiao Zhou¹, Di Deng², Chunmei Gan³

¹Medicine and Engineering Interdisciplinary Research Laboratory of Nursing and Materials, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University Chengdu 610041, Sichuan, P. R. China.

American journal of stem cells

|September 22, 2025

概括

基因疗法对遗传性听力损失 (HHL) 是一种广泛存在的疾病有前景. 克服基因传递和安全方面的挑战对于开发有效的遗传性聋症治疗方法至关重要.

科学领域:

耳鼻喉科耳鼻喉科耳鼻喉科
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

遗传性听力损失 (HHL) 影响全球超过4.66亿人.
HHL被分为综合征性 (SHL) 和非综合征性 (NSHL) 形式,目前没有对遗传原因的治疗方法.
现有的治疗方法,如助听器和耳植入物,可以治疗症状,而不是潜在的遗传缺陷.

研究的目的:

系统地审查基因治疗遗传性听力损失的进展情况.
评估阻碍临床实施HHL基因疗法的障碍.
为未来遗传性聋症的翻译研究提供见解.

主要方法:

对遗传性听力损失的基因疗法研究的系统性文献综述.
对基因疗法方法和它们在动物模型中的有效性进行当前研究的分析.
评估与病毒载体安全性,转染效率和点特异性相关的挑战.

主要成果:

基因疗法在遗传性聋的临床前模型中已经证明了治疗潜力.
临床翻译仍然面临重大挑战,包括优化载体传递和确保安全.
目前的研究突出显示,需要提高基因向的特异性和效率.

结论:

基因疗法代表了治疗遗传性听力损失的有希望的途径.
解决安全性,效率和特异性的障碍对于成功的临床应用至关重要.
需要进一步的翻译研究,才能将基因疗法从动物模型带到人类患者身上.

关键词:

腺相关病毒的病毒.头发细胞是指毛细胞.遗传性听力损失是一种遗传性听力损失.内耳的内耳是内耳的内耳.

更多相关视频

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

Digital Droplet PCR Method for the Quantification of AAV Transduction Efficiency in Murine Retina

Digital Droplet PCR Method for the Quantification of AAV Transduction Efficiency in Murine Retina

Published on: December 25, 2021

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...